FDA Rescinds 2022 Ban on Juul E-Cigarettes, Reopens Door for Clearance on Thursday

Jun 6, 2024, 04:50 PM

The U.S. Food and Drug Administration (FDA) has rescinded its June 2022 marketing denial order on Juul Labs' e-cigarette products. This decision reverts Juul's products to a pending status under scientific review. The FDA stated that the decision was influenced by new case law established in lawsuits and updated information from Juul. Although the agency has not yet reached a final determination on whether Juul's products can remain on the U.S. market, the move opens the possibility for federal clearance. During the appeal process, Juul's products remained available on the market. The FDA announced this decision on Thursday.